Restasis Multidose Emulsion
Product Images NDC 0023-5301

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Restasis Multidose (NDC 0023-5301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Restasis Multidose 01

FDA Label Image

Restasis Multidose 02

FDA Label Image

Restasis Multidose 03

FDA Label Image

Restasis Multidose 04

FDA Label Image

Restasis Multidose 05

FDA Label Image

Restasis Multidose 06

FDA Label Image

Restasis Multidose 07

FDA Label Image

Restasis Multidose 08

FDA Label Image

Restasis Multidose 09

FDA Label Image

Restasis Multidose 0a

Not available.*

FDA Label Image

Restasis Multidose 0b

FDA Label Image

Restasis Multidose 0c

FDA Label Image

Restasis Multidose 0d

FDA Label Image

Restasis Multidose 0e

FDA Label Image

Restasis Multidose 0f

FDA Label Image

Restasis Multidose 10

FDA Label Image

Restasis Multidose 11

This appears to be a label for a medication named "CONTANS At g 0055" with instructions on dosage and application. It appears to be applicable for topical use in the eyes and mentions a dosage of "vt btk." The label also indicates that the medication is only available with a prescription. The rest of the text is mostly illegible due to errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.